CNMD
CONMED Corp
NYSE · Healthcare · Medical - Devices · US
$45.42
−1.54%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$45.48
From 52W high−12.42%
Volume776977.00
Market cap$1.36B
P/E (TTM)24.5x
P/S (TTM)1.0x
Div yield—
Key dataSep 18, 2026
Open
$45.48
From 52W high
−12.42%
Volume
776977.00
Market cap
$1.36B
ValuationView details →
P/E (Fwd)
10.1x
EV/EBITDA
12.0x
P/E (TTM)
24.5x
RSI (14)
37.7
MomentumView details →
1D Return
−1.54%
YTD Return
+12.17%
SummaryUpdated Jun 1, 2026
CONMED Corporation (NYSE:CNMD) is a medical technology company founded in 1970 and headquartered in Largo, Florida. The company went public in 1987 and has grown to become a significant player in the surgical device industry, developing, manufacturing, and selling surgical equipment and related products for procedures worldwide. CONMED has built its business through both organic growth and strategic acquisitions, including notable purchases of In2Bones and Biorez in 2022, which expanded its orthopedic capabilities. The company operates globally, serving hospitals, surgery centers, and other healthcare institutions directly and through medical specialty distributors.
Similar companies
Latest newsMore news →
CONMED Corporation reported financial results for the second quarter ended June 30, 2026, with sales of $343.5 million, up 0.3% year-over-year.53d agoCONMED Corporation announced that its AirSeal Robotic Solution has received an expanded FDA-cleared indication for use with Intuitive's 8 mm hex cannulas on the da Vinci 5 platform.60d agoCONMED Corporation repurchased approximately $645.2 million aggregate principal amount of its 2.25% Convertible Senior Notes due 2027 for about $637.2 million in cash.108d ago